Golden Seeds — 2024 Investments
7 investments dated 2024 · listed companies and verified rows first · show all
Joylux develops a line of consumer products focused on women's intimate and pelvic floor health, created with input from an Ob-Gyn to address changes women experience post-delivery and with age.
Direct to ConsumerFemTechWellness & FitnessSeattle, US
Colette Courtion(Founder)inRobert Cross(Director)Richard Boxer(Director)Peter Weiss(Executive Officer)
Co-investorsCentral Texas Angel NetworkGoddessHealthtech CapitalHouston Angel NetworkJ-ImpactJ-Ventures+7 more
Rivia Health develops AI-powered patient payment automation software for specialty healthcare practices.
AI & Machine LearningEnterprise SoftwareHealthtechPhoenix, US
Rachel Mertensmeyer(Executive Officer, Director)inBrenda Schmidt(Director)
BoardGregg Scoresby(Director)in
Co-investorsDipalo VenturesEdge Case Capital PartnersMotley Fool VenturesPHX VenturesXcellerant VenturesAiSprouts VC
SunRay Scientific develops anisotropic conductive adhesives (ZTACH ACE), conductive inks, epoxies, and related materials for printed and flexible electronics, integrable with existing pick-and-place manufacturing equipment.
Advanced ManufacturingHardwareNew MaterialsWall Township, US
Andrew Stemmermann(CTO, Co-Founder)inMadhu Stemmermann(CEO, Co-Founder)in
BoardSteve Socolof(Director)in
Co-investorsBroad Street AngelsCentral Texas Angel NetworkDelaware Crossing Investor GroupJumpStart New Jersey Angel NetworkSoundboard Venture FundWestchester Angels+1 more
Uncaged Innovations is a biomaterials company that makes grain- and plant-based leather alternatives using its proprietary BioFuze platform, which replicates the collagen structure of animal leather.
Advanced ManufacturingBiotechCircular EconomyNew MaterialsWhite Plains, US
Stephanie Downs(Chief Executive Officer)in
Co-investorsAlwyn CapitalGreen Circle Foodtech VenturesPonderosa VenturesStray Dog CapitalFall Line CapitalInMotion Ventures+1 more
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(CTO)inNick Damiano(CEO)inJohn Beck(Executive Officer)in
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsAstiaCloudStone CapitalDorm RoomF-Prime CapitalShangBay Capital LLCY Combinator+15 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Egal PadsvipHomeLink
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.































